Event Videos

https://www.ncbi.nlm.nih.gov/pubmed/31117336
J Clin Res Pediatr Endocrinol. 2019 May 23. doi: 10.4274/jcrpe.galenos.2019.2018.0271. [Epub ahead of print]
Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome
Wójcik M1,2, Ruszała A1,2, Januś D1,2, Starzyk JB1,2.

Abstract

OBJECTIVE:
To investigate the prevalence of abnormal LFTs in children and adolescents with TS; to analyse LFTs changes and its clinical significance during several years of observation; to evaluate the potential impact of increased BMI and sex hormones replacemet therapy (HRT) on LFTs.

METHODS:

Published on: 
May-2019

https://www.ncbi.nlm.nih.gov/pubmed/31124886 NAFLD
J Pediatr Gastroenterol Nutr. 2019 May 18. doi: 10.1097/MPG.0000000000002401. [Epub ahead of print]

Psychotropic Medications are Associated with Increased Liver Disease Severity in Pediatric NAFLD.

Mouzaki M1, Yodoshi T1, Arce-Clachar AC1, Bramlage K1, Fei L2, Hunsaker SL3, Xanthakos SA1.

Abstract

OBJECTIVES:
To determine whether pediatric patients with non-alcoholic fatty liver disease (NAFLD) exposed to psychotropic medications have more severe liver disease compared to their counterparts who are not on these medications. We hypothesize that use of psychotropic agents is associated with liver disease severity.

METHODS:

Published on: 
May-2019

https://www.ncbi.nlm.nih.gov/pubmed/31024959 Hepatoblastoma

World J Clin Cases. 2019 Apr 6;7(7):872-880. doi: 10.12998/wjcc.v7.i7.872.

Robot-assisted gallbladder-preserving hepatectomy for treating S5 hepatoblastoma in a child: A case report and review of the literature.

Chen DX1, Wang SJ2, Jiang YN3, Yu MC2, Fan JZ4, Wang XQ5.

Abstract

BACKGROUND:

Published on: 
Apr-2019

https://www.ncbi.nlm.nih.gov/pubmed/31126688 Hepatoblastoma
J Pediatr Surg. 2019 May 11. pii: S0022-3468(19)30347-1. doi: 10.1016/j.jpedsurg.2019.05.004. [Epub ahead of print]

Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the Children's Oncology Group AHEP 0731 Liver Tumor Committee.

Weldon CB1, Madenci AL2, Tiao GM3, Dunn SP4, Langham MR5, McGahren ED6, Ranganathan S7, López-Terrada DH8, Finegold MJ8, Malogolowkin MH9, Piao J10, Huang L11, Krailo MD10, Meyers RL12, Katzenstein HM13.

Abstract

BACKGROUND:

Published on: 
May-2019

https://www.ncbi.nlm.nih.gov/pubmed/31134334 NAFLD

J Gastroenterol. 2019 May 27. doi: 10.1007/s00535-019-01594-6. [Epub ahead of print]

Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population.

Wang L1,2, Wang Y3, Liu S2, Zhai X1, Zhou G2, Lu F4, Zhao J5.

Abstract

BACKGROUND:
The interaction between nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis B infection (CBI) was unclear. We aimed to investigate the association between NAFLD and CBI and the effect of NAFLD on response to antiviral therapy in pediatric population.

METHODS:

Published on: 
May-2019

https://www.ncbi.nlm.nih.gov/pubmed/30980773 Hepatitis C

J Viral Hepat. 2019 Apr 13. doi: 10.1111/jvh.13111. [Epub ahead of print]

Treatment and Monitoring of Children with Chronic Hepatitis C in the Pre-DAA Era: a European Survey of 38 Paediatric Specialists.

Indolfi G1, Bailey H2, Serranti D1, Giaquinto C3, Thorne C2; PENTAHep Study Group.
Collaborators (51)

Abstract

Published on: 
Apr-2019

https://www.ncbi.nlm.nih.gov/pubmed/30982721 Hepatitis c

Lancet Gastroenterol Hepatol. 2019 Apr 10. pii: S2468-1253(19)30046-9. doi: 10.1016/S2468-1253(19)30046-9. [Epub ahead of print]

Hepatitis C virus infection in children and adolescents.

Indolfi G1, Easterbrook P2, Dusheiko G3, El-Sayed MH4, Jonas MM5, Thorne C6, Bulterys M7, Siberry G8, Walsh N9, Chang MH10, Meyers T11, Giaquinto C12, Wirth S13, Chan PL14, Penazzato M7.

Abstract

Published on: 
Apr-2019

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: